产品名称
5-溴-4-氯-3-吲哚磷酸 对甲苯胺盐, ≥95.0% (HPLC)
Quality Level
assay
≥95.0% (HPLC)
form
powder
storage temp.
2-8°C
SMILES string
Cc1ccc(N)cc1.OP(O)(=O)Oc2c[nH]c3ccc(Br)c(Cl)c23
InChI
1S/C8H6BrClNO4P.C7H9N/c9-4-1-2-5-7(8(4)10)6(3-11-5)15-16(12,13)14;1-6-2-4-7(8)5-3-6/h1-3,11H,(H2,12,13,14);2-5H,8H2,1H3
InChI key
QEIFSLUFHRCVQL-UHFFFAOYSA-N
General description
碱性磷酸酶的组织化学底物。
Application
用于碱性磷酸酶标记分子的比色检测。
用于碱性磷酸酶标记分子的比色检测,可使用5-溴-4-氯-3-吲哚基磷酸酯(BCIP)和硝基蓝四唑(NBT)。BCIP/NBT底物系统具有多种功能并用于多种应用,包括Northern Southern和Western blotting、原位杂交和免疫组化。
BCIP以两种盐形式提供:可溶于水的二钠盐和可溶于二甲基甲酰胺的对甲苯胺形式。这些盐形式可用于制备与NBT及反应缓冲液组合的储存溶液,并形成碱性磷酸酶的底物溶液。当与碱性磷酸酶一起孵育时,该底物系统可产生不溶的NBT二甲嗪产物,具有容易被观察到的紫色。为了方便起见,BCIP和NBT的混合物是以一种易溶解的片剂形式或作为即用型液体而提供的。
BCIP以两种盐形式提供:可溶于水的二钠盐和可溶于二甲基甲酰胺的对甲苯胺形式。这些盐形式可用于制备与NBT及反应缓冲液组合的储存溶液,并形成碱性磷酸酶的底物溶液。当与碱性磷酸酶一起孵育时,该底物系统可产生不溶的NBT二甲嗪产物,具有容易被观察到的紫色。为了方便起见,BCIP和NBT的混合物是以一种易溶解的片剂形式或作为即用型液体而提供的。
Legal Information
BCIP is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under 5-溴-4-氯-3-吲哚磷酸 对甲苯胺盐
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Fernando Cartón-García et al.
Scientific reports, 5, 12312-12312 (2015-07-24)
Inherited MYO5B mutations have recently been associated with microvillus inclusion disease (MVID), an autosomal recessive syndrome characterized by intractable, life-threatening, watery diarrhea appearing shortly after birth. Characterization of the molecular mechanisms underlying this disease and development of novel therapeutic approaches
Dorota Rybaczek et al.
Histochemistry and cell biology, 135(3), 263-280 (2011-02-25)
Here, we demonstrate that in HeLa cells, Ser317 of Chk1 undergoes phosphorylation in response to replication stress induced by hydroxyurea. We also demonstrate the existence of constitutive (interphase and mitotic) Chk1 kinase phosphorylation, the translocation of its phosphorylated form from
Karuppiah Muthumani et al.
Science translational medicine, 7(301), 301ra132-301ra132 (2015-08-21)
First identified in 2012, Middle East respiratory syndrome (MERS) is caused by an emerging human coronavirus, which is distinct from the severe acute respiratory syndrome coronavirus (SARS-CoV), and represents a novel member of the lineage C betacoronoviruses. Since its identification
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 16670-100MG | 04061833267233 |
| 16670-1G | 04061826660942 |